Chemical, Biochemical, Cellular, and Physiological Characterization of Leucettinib-21, a Down Syndrome and Alzheimer’s Disease Drug Candidate

How to repurpose your cancer drug to a Molecular RadioTherapy drug candidate

In this blog, Dr Eftychia Koumarianou deals with the ground-breaking and intriguing approach that hides behind the theranostics.

Navigating from molecules to medicines in our chemistry department

Christophe Parsy, Ph.D, MBA, head of the medicinal chemistry team since 2020, presents his team's daily challenges and missions.

Chronic inflammation and cancer: how can preclinical models revolutionize our understanding?

Olivier Duchamp discusses the development of new anti-inflammatory strategies for the prevention and treatment of cancer using a better modeling

Breast cancer awareness month

To progress through new treatments, Oncodesign Services supports since many years pharmaceutical companies with breast cancer models such as PDX and CDX models.

Targeted RNA degradation: Principle and Therapeutic Promises

RNA, or RiboNucleic Acid, is a structured macromolecule which plays a central role in numerous cellular functions.

EORTC International Conference on Molecular Targets and Cancer Therapeutics

Oncodesign Services will be attending to EORTC 2023 ! Fix a meeting now.

Meet Marie!

Every day, as an invivo research technician, Marie participates in the in vivo studies and tests the effects of a new molecule or a new product. Discover her journey and learn more about working in a lab as a technician.

Breaking Barriers in Oncology Drug Development: Unveiling the Potential of 3D Cell Models for Drug Discovery

Blog: 3D Cell models are revolutionizing Cancer Drug Development. Here, we present the main advantages to better understand tumor complexity

Leucettinibs, a Class of DYRK/CLK Kinase Inhibitors Inspired by the Marine Sponge Natural Product Leucettamine B

Dual-specificity, tyrosine phosphorylation-regulated kinases (DYRKs) and cdc2-like kinases (CLKs) recently attracted attention due to their central involvement in various pathologies.

CADD: computer tools and chemists combine to make better drug leads

Sylvain Lozano, computational chemist, explains the important role these tools play in our drug discovery journey.

Oncodesign Services receives global excellence awards

Oncodesign Services is thrilled to announce that we have been awarded 'Best Preclinical Services & Drug Discovery Company 2023 – France!